High In-Plane Resolution T2-Weighted Magnetic Resonance Imaging of Acute Myocardial Ischemia in Pigs Using the Intravascular Contrast Agent NC100150 Injection
暂无分享,去创建一个
Håkan Ahlström | Lars Johansson | Tomas Bjerner | L. Johansson | G. Wikström | H. Ahlström | T. Bjerner | Gerhard Wikström
[1] R. Brasch,et al. Rationale and applications for macromolecular Gd‐based contrast agents , 1991, Magnetic resonance in medicine.
[2] A. Bjørnerud,et al. NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive‐contrast MR angiography , 2000, Journal of magnetic resonance imaging : JMRI.
[3] A. Bjørnerud,et al. Effect of NC100150 injection on the 1H NMR linewidth of human whole blood ex vivo: Dependency on blood oxygen tension , 2000, Magnetic resonance in medicine.
[4] D N Firmin,et al. Echo‐planar magnetic resonance myocardial perfusion imaging: Parametric map analysis and comparison with thallium SPECT , 2001, Journal of magnetic resonance imaging : JMRI.
[5] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[6] G. V. von Schulthess,et al. Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography , 2001, Circulation.
[7] R. Wilson,et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. , 1997, Radiology.
[8] Håkan Ahlström,et al. Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model , 2000, Journal of magnetic resonance imaging : JMRI.
[9] Guang-Zhong Yang,et al. First‐pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection , 1999, Journal of magnetic resonance imaging : JMRI.
[10] First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients. , 2001, Radiology.
[11] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[12] D. Pennell,et al. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[13] F. Franconi,et al. High Field Magnetic Resonance Imaging Evaluation of Superparamagnetic Iron Oxide Nanoparticles in a Permanent Rat Myocardial Infarction , 2003, Investigative radiology.
[14] C. Lorenz,et al. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[15] A. Bjørnerud,et al. Assessment of T1 and T *2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state—dependence on blood volume and water exchange , 2002, Magnetic resonance in medicine.
[16] B. Sobel,et al. Estimation of Infarct Size in Man and its Relation to Prognosis , 1972, Circulation.
[17] R. Kim,et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.
[18] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[19] C H Lorenz,et al. Characterization of t1 relaxation and blood‐myocardial contrast enhancement of NC100150 injection in cardiac MRI , 1999, Journal of magnetic resonance imaging : JMRI.
[20] Maythem Saeed,et al. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. , 2002, Radiology.
[21] M E Moseley,et al. Iron–dextran as a magnetic susceptibility contrast agent: Flow‐related contrast effects in the T2‐weighted spin‐echo MRI of normal rat and cat brain , 1992, Magnetic resonance in medicine.
[22] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[23] E. Fleck,et al. Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease , 2003, Circulation.